mhurhangee/ep-ind-claims huggingface dataset:
A method for heating one or more streams from a refinery process, chosen from the group of crude tower inlet, vacuum tower inlet, catalytic reformer inlet, coker inlet, thermal cracker inlet and hydrocracker inlet, said method comprising a step of transferring, in a heat exchanger, heat from one or more streams from petro-chemistry process, chosen from the group of a gas stream coming from a steam cracker furnace, a gas stream coming from a propane dehydrogenation furnace, wherein a propane feedstream is converted into a product comprising propylene and hydrogen, and a gas stream coming from a butane dehydrogenation furnace, for converting a butane feedstream into C4 olefins, to said one or more streams from a refinery process for obtaining one or more heated streams, wherein the temperature of said one or more streams from petro-chemistry process is above the temperature of said one or more streams from a refinery process before said step of heat exchanging has taken place.
A polymer electrolyte membrane comprising: a first polymer layer and a second polymer layer provided on the first polymer layer, wherein the first polymer layer includes hydrophilic silica particles; and the second polymer layer includes hydrophobic silica particles, wherein the hydrophilic silica particle is a silica of which the surface is treated by plasma, and the hydrophobic silica particle is a silica of which the surface is modified by methylsilane. a first polymer layer and a second polymer layer provided on the first polymer layer, wherein the first polymer layer includes hydrophilic silica particles; and the second polymer layer includes hydrophobic silica particles, wherein the hydrophilic silica particle is a silica of which the surface is treated by plasma, and the hydrophobic silica particle is a silica of which the surface is modified by methylsilane.
A microsphere composition comprising rotigotine or a pharmaceutically acceptable salt thereof; at least one poly(lactide-co-glycolide) (PLGA); and at least one fatty acid, wherein the rotigotine or its pharmaceutical salt thereof is 20-40%, the at least one PLGA is 57.5-72.5%, and the at least one fatty acid is 2.5-7.5% in weight relative to the total weight of the composition.
A control system for use in treating snoring among at least two users (12, 14), each user having a respective active pillow (16, 18) associated therewith, each active pillow having a mechanism (20, 22) which produces at least two distinct motions: an anti-snoring motion which manipulates the head of a user thereof in a manner which reduces snoring and a distracting motion which manipulates the head of a user thereof in a manner which reduces noticeability of snoring by another user, the control system comprising: a sensing system structured to detect snoring by at least one of the users; and a processing unit in communication with the sensing system, the processing unit programmed to determine, from a communication with the sensing system, that snoring by at least one of the at least two users is occurring; and either: (a) determine that only one of the at least two users is snoring and responsive thereto: generate a signal to produce the anti-snoring motion in the active pillow associated with the one user, and generate another signal to produce the distracting motion in the active pillow associated with the other user; or (b) determine that both of the users are snoring and responsive thereto generate signals to produce the anti-snoring motion in each of the active pillows. a sensing system structured to detect snoring by at least one of the users; and a processing unit in communication with the sensing system, the processing unit programmed to determine, from a communication with the sensing system, that snoring by at least one of the at least two users is occurring; and either: (a) determine that only one of the at least two users is snoring and responsive thereto: generate a signal to produce the anti-snoring motion in the active pillow associated with the one user, and generate another signal to produce the distracting motion in the active pillow associated with the other user; or (b) determine that both of the users are snoring and responsive thereto generate signals to produce the anti-snoring motion in each of the active pillows. (a) determine that only one of the at least two users is snoring and responsive thereto: generate a signal to produce the anti-snoring motion in the active pillow associated with the one user, and generate another signal to produce the distracting motion in the active pillow associated with the other user; or generate a signal to produce the anti-snoring motion in the active pillow associated with the one user, and generate another signal to produce the distracting motion in the active pillow associated with the other user; or (b) determine that both of the users are snoring and responsive thereto generate signals to produce the anti-snoring motion in each of the active pillows.
An oven door for an oven cavity of a cooking oven, wherein - the oven door comprises a first unit (12, 28) and a second unit (14, 20), - the first unit includes a front panel and at least two door columns permanently attached at an inner side of said front panel relating to a mounted state and closed position of the oven door, - the second unit includes an inner glass panel and a door frame permanently attached at said inner glass panel, - the door frame includes an upper frame part and two lateral frame parts relating to the mounted state and closed position of the oven door, - the lateral frame parts are permanently attached at an outer side of the inner glass panel relating to the mounted state and closed position of the oven door, - the upper frame part is permanently attached at upper ends of the lateral frame parts relating to the mounted state and closed position of the oven door, - the lateral frame parts are connected or connectable to the door columns in each case, so that the first unit (12, 28) and the second unit (14, 20) are detachably or permanently connected or connectable, and - a ventilation opening is formed between the inner glass panel and the upper frame part, characterised in that the ventilation opening is formed by a cut-out in the inner glass panel, so that a lower side and lateral sides of said ventilation opening are bordered by the inner glass panel and an upper side of said ventilation opening is bordered by the upper frame part, wherein either an inner side of the upper frame part is in the same plane as the inner side of the inner glass panel or the upper frame part protrudes inwardly. - the oven door comprises a first unit (12, 28) and a second unit (14, 20), - the first unit includes a front panel and at least two door columns permanently attached at an inner side of said front panel relating to a mounted state and closed position of the oven door, - the second unit includes an inner glass panel and a door frame permanently attached at said inner glass panel, - the door frame includes an upper frame part and two lateral frame parts relating to the mounted state and closed position of the oven door, - the lateral frame parts are permanently attached at an outer side of the inner glass panel relating to the mounted state and closed position of the oven door, - the upper frame part is permanently attached at upper ends of the lateral frame parts relating to the mounted state and closed position of the oven door, - the lateral frame parts are connected or connectable to the door columns in each case, so that the first unit (12, 28) and the second unit (14, 20) are detachably or permanently connected or connectable, and - a ventilation opening is formed between the inner glass panel and the upper frame part,
An intermediate carrier device for holding a scrunched bag having an open end and a closed base and forming a transportable container to support a plurality of bulk goods comprising: a rigid carrier base disposed about a base axis AB; Characterized in that it also comprises: a plurality of carrier arms being pivotally connected to said carrier base by a pivotal connection and extending between a first arm end and a second arm end, each of said carrier arms extending from said carrier base for holding the bag in a scrunched position, and wherein each of said carrier arms are pivotally connected by said pivotal connection to said carrier base at said first arm end for pivoting each of said carrier arms at said first arm end to allow said second arm end to move radially inward and outward; and an elastomeric joint disposed adjacent said pivotal connection between each of said first arm ends and said carrier base for biasing each of said second arm ends radially outward to provide tension against the bag from each of said second arm ends and hold the bag in the scrunched position. a plurality of carrier arms being pivotally connected to said carrier base by a pivotal connection and extending between a first arm end and a second arm end, each of said carrier arms extending from said carrier base for holding the bag in a scrunched position, and wherein each of said carrier arms are pivotally connected by said pivotal connection to said carrier base at said first arm end for pivoting each of said carrier arms at said first arm end to allow said second arm end to move radially inward and outward; and an elastomeric joint disposed adjacent said pivotal connection between each of said first arm ends and said carrier base for biasing each of said second arm ends radially outward to provide tension against the bag from each of said second arm ends and hold the bag in the scrunched position.
A substantially pure population of amniotic fluid-derived cells, wherein said cells are: capable of differentiating into cells displaying the characteristics of the beta-cell lineage, substantially negative for the expression of the CD117 and Oct-4 protein markers, wherein the markers are not present or expressed in at least 70% of the total cell population, substantially positive for the expression of GATA-6 and SSEA-4, wherein GATA-6 and SSEA-4 are present or expressed in at least about 50% of the total cell population, and substantially either i) positive for the expression of SOX-17 and cytokeratin, wherein SOX-17 and cytokeratin are present or expressed in at least about 50% of the total cell population; ii) negative for the expression of SOX-17, wherein SOX-17 is not present or expressed in at least 70% of the total cell population, and positive in the expression of cytokeratin, wherein cytokeratin is present or expressed in at least about 50% of the total cell population; or iii) negative for the expression of SOX-17 and cytokeratin, wherein SOX-17 and cytokeratin are not present or expressed in at least 70% of the total cell population. capable of differentiating into cells displaying the characteristics of the beta-cell lineage, substantially negative for the expression of the CD117 and Oct-4 protein markers, wherein the markers are not present or expressed in at least 70% of the total cell population, substantially positive for the expression of GATA-6 and SSEA-4, wherein GATA-6 and SSEA-4 are present or expressed in at least about 50% of the total cell population, and substantially either i) positive for the expression of SOX-17 and cytokeratin, wherein SOX-17 and cytokeratin are present or expressed in at least about 50% of the total cell population; ii) negative for the expression of SOX-17, wherein SOX-17 is not present or expressed in at least 70% of the total cell population, and positive in the expression of cytokeratin, wherein cytokeratin is present or expressed in at least about 50% of the total cell population; or iii) negative for the expression of SOX-17 and cytokeratin, wherein SOX-17 and cytokeratin are not present or expressed in at least 70% of the total cell population. i) positive for the expression of SOX-17 and cytokeratin, wherein SOX-17 and cytokeratin are present or expressed in at least about 50% of the total cell population; ii) negative for the expression of SOX-17, wherein SOX-17 is not present or expressed in at least 70% of the total cell population, and positive in the expression of cytokeratin, wherein cytokeratin is present or expressed in at least about 50% of the total cell population; or iii) negative for the expression of SOX-17 and cytokeratin, wherein SOX-17 and cytokeratin are not present or expressed in at least 70% of the total cell population.
Drivetrain for a motor vehicle, having - an internal combustion engine and a starter device, wherein the internal combustion engine can be started by means of the starter device, - a gearbox arrangement via which the drive power can be conducted from the internal combustion engine to an output of the motor vehicle and which has at least one component (23; 32) which can be actuated in a manner which can be automated, and - an actuator arrangement, which has at least one electric actuator motor (52; 78), by means of which the at least one component (23; 32) of the gearbox arrangement can be actuated, wherein the at least one electric actuator motor (52; 78) is coupled to the starter device in order to be able to start the internal combustion engine by means of the at least one electric actuator motor (52; 78), characterized in that the starter device has a hydraulic motor, by means of which the internal combustion engine can be started, wherein the hydraulic motor can be connected to a fluid line of a hydraulic circuit of the actuator arrangement, wherein the hydraulic circuit has an actuator pump, which is driven by means of the at least one electric actuator motor and is designed to provide a fluid volume flow for driving the hydraulic motor in the fluid line. - an internal combustion engine and a starter device, wherein the internal combustion engine can be started by means of the starter device, - a gearbox arrangement via which the drive power can be conducted from the internal combustion engine to an output of the motor vehicle and which has at least one component (23; 32) which can be actuated in a manner which can be automated, and - an actuator arrangement, which has at least one electric actuator motor (52; 78), by means of which the at least one component (23; 32) of the gearbox arrangement can be actuated,
Tray sealer comprising a gripper device with two gripper arms, a supply device for unsealed trays, a removal device for sealed trays and a sealing device for sealing the trays, characterized in that each gripper arm comprises a coupling device that is configured to receive a first tray gripper for supplying trays into said sealing device and a second tray gripper for removing trays from said sealing device.
A method of sealing a fluid within a container (100; 47; 57; 60), comprising: providing a container (100; 47; 57; 60) having an opening; adding a fluid (140; 64, 65) to the container (100; 47; 57; 60); and sealing the opening, wherein the container (100; 47; 57; 60) is constructed from acrylates, (meth)acrylates, vinylethers, esters, epoxides, polyethylene terephthalate, high-density polyethylene (HDPE), polypropylene, polyvinyl chloride, or cellulose; prior to adding the fluid (140; 64, 65) to the container (100; 47; 57; 60), at least a portion of the container surrounding the opening is coated with a first mixture (120; 32), characterised in that the first mixture comprises a phenethylamine and a first, swellable polymer; and in that after adding the fluid (140; 64, 65) to the container (100; 47; 57; 60), the portion of the container coated with the first mixture (120; 32) is contacted with a second mixture (160; 36), comprising a second, hydrophilic polymer, whereby the first and second polymers interact to seal the container (100; 47; 57; 60). providing a container (100; 47; 57; 60) having an opening; adding a fluid (140; 64, 65) to the container (100; 47; 57; 60); and sealing the opening, wherein the container (100; 47; 57; 60) is constructed from acrylates, (meth)acrylates, vinylethers, esters, epoxides, polyethylene terephthalate, high-density polyethylene (HDPE), polypropylene, polyvinyl chloride, or cellulose; prior to adding the fluid (140; 64, 65) to the container (100; 47; 57; 60), at least a portion of the container surrounding the opening is coated with a first mixture (120; 32), characterised in that the first mixture comprises a phenethylamine and a first, swellable polymer; and in that after adding the fluid (140; 64, 65) to the container (100; 47; 57; 60), the portion of the container coated with the first mixture (120; 32) is contacted with a second mixture (160; 36), comprising a second, hydrophilic polymer, whereby the first and second polymers interact to seal the container (100; 47; 57; 60).
An information verification method, wherein the method comprises: receiving, by a user equipment, a remote profile management command sent by a first profile server, wherein the remote profile management command comprises a first profile owner identifier; in response to a determination that the first profile owner identifier exists in profile information, executing, by the user equipment, the remote profile management command; wherein before receiving, by a user equipment, the remote profile management command, the method further comprises: receiving, by the user equipment, an update message, wherein the update message comprises an identifier of the first profile server and the first profile owner identifier sent by a remote profile management, RPM, server or a second profile server. receiving, by a user equipment, a remote profile management command sent by a first profile server, wherein the remote profile management command comprises a first profile owner identifier; in response to a determination that the first profile owner identifier exists in profile information, executing, by the user equipment, the remote profile management command; wherein before receiving, by a user equipment, the remote profile management command, the method further comprises: receiving, by the user equipment, an update message, wherein the update message comprises an identifier of the first profile server and the first profile owner identifier sent by a remote profile management, RPM, server or a second profile server.
A pharmaceutical composition for use in a method for preventing or treating at least one side-effect associated with tetrahydrocannabinol consumption, wherein said side-effect is selected from increased appetite and/or body-weight gain, confusion and/or disorientation, or anxiety, wherein the composition comprises a therapeutically-effective amount of a mixture of at least one cannabinoid, wherein the at least one cannabinoid is tetrahydrocannabinol or a salt thereof, and at least one N-acylethanolamine or a salt thereof, wherein the at least one N-acylethanolamine is N-palmitoylethanolamine or a salt thereof, wherein the molar ratio between the cannabinoid and the N-acylethanolamine is between about 1:0.2 to about 1:2000.
A polypeptide binding to fibroblast growth factor receptor 3 isoforms 3b and 3c (FGFR3b and FGFR3c), wherein the polypeptide comprises an amino acid sequence selected from the group consisting of: (a) GVTLFVALYDYEVYGPTPMLSFHKGEKFQIL(X 1)(X 2)(X 3)(X 4)GPYWEA RSL(X 5)TGETG(X 6)IPSNYVAPVDSIQ (SEQ ID NO: 1); wherein amino acid positions (X 1) to (X 6) may be any amino acid sequence; and (b) an amino acid sequence which is at least 95% identical to the amino acid sequence of (a), wherein the identity determination excludes amino acid positions (X 1) to (X 6) and provided that the amino acid sequence EVYGPTPM (SEQ ID NO: 2) in amino acid positions 12 to 19 of SEQ ID NO: 1 is conserved and the amino acids P and Y in amino acid positions 37 and 38 of SEQ ID NO: 1 are conserved; (c)GVTLFVALYDYEVMSTTALSFHKGEKFQILSQSPHGQYWEARSLTTGET G(X 6)IPSNY VAPVDSIQ (SEQ ID NO: 19), wherein the amino acid position (X 6) may be any amino acid; and (d) an amino acid sequence which is at least 95% identical to the amino acid sequence of (c), wherein the identity determination excludes amino acid position (X 6) and provided that the amino acid sequences EVMSTTA (SEQ ID NO: 20) in amino acid positions 12 to 18 of SEQ ID NO: 19 and SQSPH (SEQ ID NO: 21) in amino acid positions 31 to 35 of SEQ ID NO: 19 are conserved and the amino acids Q and Y in amino acid positions 37 and 38 of SEQ ID NO: 19 are conserved. (a) GVTLFVALYDYEVYGPTPMLSFHKGEKFQIL(X 1)(X 2)(X 3)(X 4)GPYWEA RSL(X 5)TGETG(X 6)IPSNYVAPVDSIQ (SEQ ID NO: 1); wherein amino acid positions (X 1) to (X 6) may be any amino acid sequence; and (b) an amino acid sequence which is at least 95% identical to the amino acid sequence of (a), wherein the identity determination excludes amino acid positions (X 1) to (X 6) and provided that the amino acid sequence EVYGPTPM (SEQ ID NO: 2) in amino acid positions 12 to 19 of SEQ ID NO: 1 is conserved and the amino acids P and Y in amino acid positions 37 and 38 of SEQ ID NO: 1 are conserved; (c)GVTLFVALYDYEVMSTTALSFHKGEKFQILSQSPHGQYWEARSLTTGET G(X 6)IPSNY VAPVDSIQ (SEQ ID NO: 19), wherein the amino acid position (X 6) may be any amino acid; and (d) an amino acid sequence which is at least 95% identical to the amino acid sequence of (c), wherein the identity determination excludes amino acid position (X 6) and provided that the amino acid sequences EVMSTTA (SEQ ID NO: 20) in amino acid positions 12 to 18 of SEQ ID NO: 19 and SQSPH (SEQ ID NO: 21) in amino acid positions 31 to 35 of SEQ ID NO: 19 are conserved and the amino acids Q and Y in amino acid positions 37 and 38 of SEQ ID NO: 19 are conserved.
A method of making a custom made cigar comprising the steps of: (a) a consumer purchasing a plurality of smokable sheets (100, 100', 100") each having first and second longitudinal edge portions and first and second faces, and a plurality of openings adjacent the first longitudinal edge portion, wherein the plurality of sheets (100, 100', 100") are bound together by a plurality of loops extending through at least one of the plurality of openings of each of the plurality of sheets (100, 100', 100"), and wherein the bound plurality of sheets (100, 100', 100") are packaged for sale; (b) removing one of the plurality of sheets (100, 100', 100") from the state of being bound by the plurality of loops wherein a plurality of the openings on the removed sheet are placed in an open state; (c) adding a selected smokable filler material to the first face of the removed sheet; (e) rolling the removed sheet together with the selected smokable filler such that the plurality of perforations in the open state extends over the second face of the removed sheet in a sealing area, wetting at least one of the sealing area and plurality of perforations in the open state, and placing pressure on the plurality of perforations in the open state so that the first longitudinal edge portion tends to stick to the second face of the removed sheet, and thereby forming a custom-tailored rolled smoking product. (a) a consumer purchasing a plurality of smokable sheets (100, 100', 100") each having first and second longitudinal edge portions and first and second faces, and a plurality of openings adjacent the first longitudinal edge portion, wherein the plurality of sheets (100, 100', 100") are bound together by a plurality of loops extending through at least one of the plurality of openings of each of the plurality of sheets (100, 100', 100"), and wherein the bound plurality of sheets (100, 100', 100") are packaged for sale; (b) removing one of the plurality of sheets (100, 100', 100") from the state of being bound by the plurality of loops wherein a plurality of the openings on the removed sheet are placed in an open state; (c) adding a selected smokable filler material to the first face of the removed sheet; (e) rolling the removed sheet together with the selected smokable filler such that the plurality of perforations in the open state extends over the second face of the removed sheet in a sealing area, wetting at least one of the sealing area and plurality of perforations in the open state, and placing pressure on the plurality of perforations in the open state so that the first longitudinal edge portion tends to stick to the second face of the removed sheet, and thereby forming a custom-tailored rolled smoking product.